Real World Canadian Case Series: Use of Tildrakizumab for Moderate to Severe Psoriasis Plaque Psoriasis: Background, Pathophysiology, Etiology Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non lesional and lesional skin Annals of the Rheumatic Diseases Many treatment guidelines for psoriasis rely heavily on body surface area (BSA) involvement to determine disease severity and eligibility for systemic therapies like biologics. Traditionally, patients with less than 10% BSA involvementespecially Erythrodermic Flare Up of Psoriasis with Uncontrolled, Undiagnosed Diabetes Mellitus: A Case Report Topical Management of Plaque PsoriasisA Review and Case Series Discussion with Focus on Aryl Hydrocarbon Receptor Modulation JCAD The Journal of Clinical and Aesthetic Dermatology